Loading...

NATCOPHARM Natco Pharma Ltd Management Changes Announcement

Ntc

NTCP

Natco Pharma Ltd

(NATCOPHARM)

2024 Announcement

Show Summary

Show Summary

FDA Inspection Results

Investor Meeting

Q4 FY25 Earnings

Volume Movement Clarification

Earnings Call Update

Financial Results Published

Earnings Presentation

Annual Compliance Report

Management Changes

Earnings Call Scheduled

Compliance Certificate

Risdiplam Legal Update

Management Change

Management Change

Management Change

Management Change

Investor Meeting

Tax Demand Order

Q3 FY25 Earnings

Earnings Call Audio

Newspaper Publication

Q3 FY25 Earnings

Director Resignation

Earnings Call Update

Bosentan Approval

Earnings Call Notice

Product Approval

GST Order Penalty

Compliance Certificate

Sustainability Report

Land Sale Announcement

Q2 Earnings Results

ANDA Submission

Investment Sale

Management Change

Dividend Announcement

Dividend Update

Earnings Call Recording

Dividend Announcement

Q2 FY25 Presentation

Management Change

Earnings Call Scheduled

Management Change

SEBI Compliance Certificate

Patent Settlement Update

Management Change

Investor Meeting

Investor Meeting

Investor Meeting

41st AGM Notice

NATCO Invests $8M

Investor Meet Notice

ANDA Submission

Investor Meeting

Q1 FY25 Earnings Update

Earnings Call Transcript

Interim Dividend Declared

Q1 FY25 Presentation

Management Changes

Investor Meeting

Delay in Resignation Submis...

Management Change

Investor Meeting

Management Change

earnings call transcript

ANDA Submission for Rimegep...

Investor Presentation

Financial Results Publication

Investor Presentation

Compliance Report Submission

Investor Meeting

Investor Meeting

USFDA Inspection

Investor Meeting

FDA Inspection Update

Compliance Certificate Subm...

Compliance Certification

Submission of PCS Certificate

Investor Meeting

Management Change

Newspaper Publications

Earnings Conference Call

Newspaper Publication

Q3 FY24 Investor Presentation

Restart of Factory Operations

Management Appointments

Acquisition of Eywa Pharma ...

Investment in Cellogen Ther...

Certificate Submission

Management Change

Dismissal from Lawsuit

Disruption of Operations

Investor Meeting

Earnings Conference Call

Uploaded audio recording

Investor Presentation

Resignation of Vice Preside...

Publication Advertisements

Earnings Report

Completion of Inspection

US FDA Inspection

Certificate submission

AGM Proceedings Announcement

Acquisition of ISCA, Inc.

Financial Statements

Financial Statements

Financial Statements

Audio Recording Uploaded

Financial Statements

Conference Call

External Links:

Data:

NATCO Pharma Ltd. has appointed three new Independent Directors: Sri Lakshminarayana Bolisetty, Smt. Kantipudi Suma, and Sri Nitin Jain for five years starting from 12th August 2024; they will seek shareholders approval at the upcoming AGM.

AI Assistant

Natco Pharma Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.